SCHEMBL28929164

SCHEMBL28929164

COc1c(Cl)cc(Cl)c2ccc(Nc3cc(N4CCOCC4)ccn3)nc12

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 6/20 0.43
▸ INSR P06213 1/20 0.42
▸ ALK Q9UM73 1/20 0.42
▸ PRKDC P78527 1/20 0.41
▸ LRRK2 Q5S007 1/20 0.41
▸ IKBKE Q14164 1/20 0.41
▸ TBK1 Q9UHD2 1/20 0.41
▸ TYK2 P29597 1/20 0.40
▸ TNIK Q9UKE5 2/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ IGF1R P08069 1/20 0.39
▸ AURKA O14965 1/20 0.39
▸ AURKB Q96GD4 1/20 0.39
▸ MAPK10 P53779 1/20 0.38
▸ ABL1 P00519 1/20 0.38
▸ JAK2 O60674 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28660399 0.90 ALDH1A1 (0.39) ALK
SCHEMBL28654896 0.89 BRD4 (0.45) IKBKETBK1TNIKABL1
SCHEMBL28663832 0.86 INSR (0.46) CHEK1INSRALKLRRK2IKBKE
SCHEMBL28929167 0.81 EGFR (0.40) INSRALKTYK2TNIKKCNH2
SCHEMBL28660407 0.75 BRD4 (0.52) IKBKETBK1TNIK
SCHEMBL28929166 0.74 — —
SCHEMBL28672733 0.70 MAPT (0.51) CHEK1LRRK2IKBKETBK1IGF1R
SCHEMBL25769210 0.68 CHEK1 (0.53) CHEK1IKBKETBK1IGF1RMAPK10
SCHEMBL28053893 0.66 ALK (0.63) CHEK1INSRALKLRRK2TBK1
SCHEMBL28663835 0.66 KDM4E (0.42) INSRALKLRRK2TNIKKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113717158-A 2- (N- (pyridine-2-yl) amino) quinoline derivative and application thereof 河南省人民医院 2021-11-30 — — CN claimed
CN-113717158-A 2- (N- (pyridine-2-yl) amino) quinoline derivative and application thereof 河南省人民医院 2021-11-30 — — CN disclosed
Send feedback